AstraZeneca Share Chat (AZN)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
AstraZeneca	LSE:AZN	London	Ordinary Share	GB0009895292	ORD SHS $0.25

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+29.00p	+0.57%	5,152.00p	5,154.00p	5,156.00p	5,172.00p	5,120.00p	5,135.00p	1,932,147	16:35:03

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	18,627.4	2,876.5	224.3	24.1	65,205.81

AstraZeneca Share Discussion Threads

Showing 10351 to 10373 of 10375 messages

Chat Pages: 415 414 413 412 411 410 409 408 407 406 405 404 Older

Date	Subject	Author	Discuss
21/7/2017 09:57	Sold half.	philanderer	Read Full Thread Reply
16/7/2017 10:04	Closed around £51-70 equivalent at current xrates in New York.	steeplejack	Read Full Thread Reply
14/7/2017 23:00	Should bounce on Monday, especially as RSI was heading to oversold.	bluemango	Read Full Thread Reply
14/7/2017 22:58	14 JULY 2017 • 9:10PM Pascal Soriot will remain at FTSE 100 pharmaceuticals firm AstraZeneca, sources said on Friday, rebuffing rumours that he was planning a move to rival Israeli drugs giant Teva Pharmaceuticals. Mr Soriot will host a call with analysts on AstraZeneca's second-quarter earnings at the end of the month as planned, AstraZeneca said. A spokesman for AstraZeneca said the company never commented on speculation and did not respond to rumours. AstraZeneca's US-listed shares lifted 4pc on the news, which was first reported by Bloomberg. hTTp://www.telegraph.co.uk/business/2017/07/14/pascal-soriot-looks-set-stay-astrazeneca-chief/	bluemango	Read Full Thread Reply
14/7/2017 22:06	According to Bloomberg Pascal's staying...... AZN in the USA. +4%	philanderer	Read Full Thread Reply
14/7/2017 10:14	Markets no something	stevenrevell	Read Full Thread Reply
14/7/2017 10:05	Aren't the Int results out soon? I know the reasons for the CEO rumoured to leave but shares normally rise into results, is there something that we don't know??	utyinv	Read Full Thread Reply
13/7/2017 12:34	Citi comment: In the event the CEO's departure is confirmed. Mene Pangalos, current head of AZN research and early development is the highest probability internal candidate, as well as Sean Bohen (CMO), in our view. We also suspect AZN's board has identified additional external candidates as part of the succession planning process. HTTPS://ftalphaville.ft.com/marketslive/2017-07-13/	philanderer	Read Full Thread Reply
13/7/2017 09:42	If Company was aware of share price sensitive news listing regulations would require them to update Market immediately. Concern is delay in responding to Soriot news and share price movement which suggests an internal battle to persuade Soriot to stay. However, regulations will come into play and force a clarification. Either he stays or AZN rudderless while industry deckchairs realigned - perfect window for opportunist offer!	scallywagkid	Read Full Thread Reply
13/7/2017 09:15	Agree with Phil - thought his leaving would be a plus not a disaster. Unless he is leaving a few skeletons in the cupboard? Not a golden reign	ganthorpe	Read Full Thread Reply
13/7/2017 09:14	I think we may get another drop soon and hopefully a bargain	stevenrevell	Read Full Thread Reply
13/7/2017 08:58	I think the market is making a link between him leaving and the imminent massive news on the lung cancer drug.	billytkid2	Read Full Thread Reply
13/7/2017 08:42	Cavalry to the rescue ;-) 13th july Citigroup buy tp 6000p 13th july Liberum buy tp 5500p reiterations.	philanderer	Read Full Thread Reply
13/7/2017 08:40	Is this fella really worth 4% of the market cap !!	philanderer	Read Full Thread Reply
13/7/2017 00:52	explains the late 3% drop in the States, thanks for the info.	drectly	Read Full Thread Reply
13/7/2017 00:32	So back under 5000p in the morning then ?	philanderer	Read Full Thread Reply
12/7/2017 09:05	12th july Jefferies hold tp 5300p cut from 5500p	philanderer	Read Full Thread Reply
06/7/2017 21:19	AstraZeneca sells off Fairfax campus for $50M HTTP://www.delawareonline.com/story/money/real-estate/2017/07/06/astrazeneca-sells-off-fairfax-campus-55-m/454706001/	philanderer	Read Full Thread Reply
03/7/2017 13:21	AstraZeneca to rake in more than £450m on two drug sales HTTP://www.telegraph.co.uk/business/2017/07/03/astrazeneca-rake-450m-two-drug-sales/?utm_source=dlvr.it&utm_medium=twitter	philanderer	Read Full Thread Reply
03/7/2017 10:13	3rd july Barclays 'overweight' tp 6300p up from 6000p	philanderer	Read Full Thread Reply
30/6/2017 15:21	Drugmakers’ Payments to U.K. Health Groups and Doctors Climb 25% HTTPS://www.bloomberg.com/news/articles/2017-06-30/drugmakers-payments-to-u-k-health-groups-doctors-climb-25?cmpid=socialflow-twitter-business&utm_content=business&utm_campaign=socialflow-organic&utm_source=twitter&utm_medium=social	philanderer	Read Full Thread Reply
30/6/2017 14:39	30th june Deutsche buy tp 5700p reiterates	philanderer	Read Full Thread Reply
26/6/2017 17:12	'Pioneering British firm wins patent for 'cancer vaccines' technology' A pioneering British pharmaceutical company has won a European patent for its ‘cancer vaccines’ technology, which if successful could revolutionise treatment of the disease. Scancell, which is listed on London’s AIM market, has been awarded the patent for its DNA ImmunoBody scientific platform, which underpins its pipeline of potential cancer vaccines. .........Much larger FTSE 100 rival AstraZeneca is due to publish eagerly-awaited phase three clinical data this summer from a trial called Mystic, testing one of its own promising IO ‘checkpoint’ therapies in lung cancer patients. HTTP://www.telegraph.co.uk/business/2017/06/26/pioneering-british-firm-wins-patent-cancer-vaccines-technology/	philanderer	Read Full Thread Reply

Chat Pages: 415 414 413 412 411 410 409 408 407 406 405 404 Older